Literature DB >> 30827235

Role of Probiotics in Prophylaxis of Helicobacter pylori Infection.

Kashyapi Chakravarty1, Smriti Gaur1.   

Abstract

Helicobacter pylori, a pathogenic bacterium, has been known to be the root cause of numerous gastrointestinal disorders. In patients showing symptoms of its infection, antibiotic therapy is a likely treatment. However, the high cost of antibiotic therapy, associated antibiotic resistance along with other adverse effects has led to the use of probiotics for Helicobacter pylori treatment. In recent times, probiotics have played an essential role as complementary prophylaxis for gastrointestinal diseases, thus minimizing antibiotics' usage and their side effects. Probiotics are live microbial agents that exude beneficial effects on their hosts when administered in the proper dosage. The growth of the organism has been reported to be inhibited to a great extent by probiotics and research employing animal models has shown a significant reduction in H. pylori-associated gastric inflammation. In human clinical trials, it has been observed that treatment with probiotics alleviated gastritis symptoms caused by H. pylori and reduced colonization of the organism. As expected, complete eradication of H. pylori infection has not yet been reported by the administration of probiotics alone. Complement treatments using probiotics have shown to benefit infected individuals by decreasing the harmful effects of H. pylori eradication treatment using antibiotics. Long-term administration of probiotics might have favourable outcomes in H. pylori infection especially by decreasing the risk of development of diseases caused by increased levels of gastric inflammation. One such chronic condition is gastric ulcer which occurs due to considerable damage to the mucosal barrier by H. pylori colonization. This review provides a brief description of the promising role of probiotics as a complementary treatment to control H. pylori infection and consequently the management of various gastrointestinal disorders among populations with a special focus on gastric ulcer. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Helicobacter pylori; Probiotics; complement treatment; gastric inflammation; gastric ulcer; gastrointestinal disorders.

Mesh:

Year:  2019        PMID: 30827235     DOI: 10.2174/1389201020666190227203107

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  7 in total

Review 1.  Antimicrobial Resistance in Companion Animals: A New Challenge for the One Health Approach in the European Union.

Authors:  Ana Marco-Fuertes; Clara Marin; Laura Lorenzo-Rebenaque; Santiago Vega; Laura Montoro-Dasi
Journal:  Vet Sci       Date:  2022-04-24

2.  Consumption of a Gelatin Supplemented with the Probiotic Strain Limosilactobacillus fermentum UCO-979C Prevents Helicobacter pylori Infection in a Young Adult Population Achieved.

Authors:  Cristian Parra-Sepúlveda; Kimberly Sánchez-Alonzo; Joaquín Olivares-Muñoz; Cristian Gutiérrez-Zamorano; Carlos T Smith; Romina I Carvajal; Katia Sáez-Carrillo; Carlos González; Apolinaria García-Cancino
Journal:  Foods       Date:  2022-06-07

3.  Gastroprotective Effects of Periplaneta americana L. Extract Against Ethanol-Induced Gastric Ulcer in Mice by Suppressing Apoptosis-Related Pathways.

Authors:  Shu Fu; Jiamei Chen; Chen Zhang; Jinfeng Shi; Xin Nie; Yichen Hu; Chaomei Fu; Xiaofang Li; Jinming Zhang
Journal:  Front Pharmacol       Date:  2021-12-15       Impact factor: 5.810

Review 4.  Relationship between Helicobacter pylori infection and gastrointestinal microecology.

Authors:  Wenting Xu; Liming Xu; Chengfu Xu
Journal:  Front Cell Infect Microbiol       Date:  2022-08-18       Impact factor: 6.073

5.  In Vitro Framework to Assess the Anti-Helicobacter pylori Potential of Lactic Acid Bacteria Secretions as Alternatives to Antibiotics.

Authors:  Samantha A Whiteside; Mahi M Mohiuddin; Sargon Shlimon; Jaspreet Chahal; Chad W MacPherson; Jana Jass; Thomas A Tompkins; Carole Creuzenet
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

6.  The Exopolysaccharide of Lactobacillus fermentum UCO-979C Is Partially Involved in Its Immunomodulatory Effect and Its Ability to Improve the Resistance against Helicobacter pylori Infection.

Authors:  Valeria Garcia-Castillo; Guillermo Marcial; Leonardo Albarracín; Mikado Tomokiyo; Patricia Clua; Hideki Takahashi; Haruki Kitazawa; Apolinaria Garcia-Cancino; Julio Villena
Journal:  Microorganisms       Date:  2020-03-27

7.  Bacterial compositions of indigenous Lanna (Northern Thai) fermented foods and their potential functional properties.

Authors:  Chonthicha Pakwan; Thararat Chitov; Panuwan Chantawannakul; Manop Manasam; Sakunnee Bovonsombut; Terd Disayathanoowat
Journal:  PLoS One       Date:  2020-11-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.